Delta Grand Pharma

Delta Grand Pharma, a core subsidiary of China Grand Pharmaceutical and Healthcare Holdings, is a leading comprehensive pharmaceutical enterprise based in Wuhan, China. The company specializes in the research, development, and large-scale manufacturing of high-quality pharmaceutical products across several critical therapeutic areas, including cardiovascular emergency medicine, ophthalmology, and otorhinolaryngology (ENT). It maintains a dominant market position in China for specialized medicines such as epinephrine and various ophthalmic preparations. Delta Grand Pharma operates multiple GMP-certified manufacturing facilities and is actively expanding its portfolio through internal R&D and strategic international partnerships. The company is increasingly focused on transitioning from a traditional generics manufacturer to an innovation-driven pharmaceutical player with a global reach.